NCT01424761View on ClinicalTrials.gov

Coenzyme Q10 in Relation to the Antioxidative Vitamins, Oxidative Stress and Inflammation in Coronary Artery Disease Patients During Statin Therapy

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

March 31, 2013

Study Completion Date

March 31, 2013

Conditions
Coronary Artery Disease
Interventions
DIETARY_SUPPLEMENT

Coenzyme Q10

Coenzyme Q10 300 mg/d (150 mg/bid)

OTHER

Placebo

Placebo :starch

Trial Locations (1)

Unknown

Taichung Verterans General Hospital, Taichung

All Listed Sponsors
lead

Taichung Veterans General Hospital

OTHER

NCT01424761 - Coenzyme Q10 in Relation to the Antioxidative Vitamins, Oxidative Stress and Inflammation in Coronary Artery Disease Patients During Statin Therapy | Biotech Hunter | Biotech Hunter